we help people discover new opportunities

Our values

Our mission

Every day, we help people expand their range of possibilities, accompanying them throughout their entire journey of interaction with the world.

Our history

2014

First drawings

  • Development of the first drawings and 3D-printing of prostheses.
2015

The first active prosthesis and production

  • Development of the CYBI prosthetic hand.
  • Obtaining the Skolkovo resident status.
  • Opening of the first production site in Moscow and prosthetic centres in Moscow and St. Petersburg.
2016

The first bionics

  • Release of the CYBI prosthetic forearm.
  • Development of the first bionic prosthesis in Russia.
  • Development of gaming attachments.
2017

More opportunities for users

  • Development of the INDY prosthetic forearm.
  • Together with the Alfa Bank, we have developed the world's first prosthesis with a built-in NFC chip for convenient contactless payments.
2018

More opportunities for doctors

  • Commercialisation of prostheses.
  • Pioneering of VR rehabilitation: we launched a tele-rehabilitation platform.
  • Presentation of the MyoBox HW and SW system for EMG signal evaluation for doctors.
  • Together with Beeline, we launched the world's first project for remote monitoring of assistive devices.
2019-2020

Product improvement

  • Development of the Manifesto prosthetic forearm.
  • Redesign and updating of the prosthesis structures.
  • Launch of the first prosthetic gadget in Russia in collaboration with Samsung Research Russia and ITMO. Owing to the built-in Galaxy Watch, the user now has the ability to control the device and analyse telemetry.
2021

Research and scaling

  • Development of the Manifesto prosthetic hand.
  • Development of touchscreen finger cots.
  • Together with FEFU and Skoltech, we initiated invasive studies for sensitisation of prosthetic arms and legs, and phantom pain management.
  • Start of sales in India.
2022-2023

The largest medtech company

  • Presentation of a prototype NEMO Sensitive neuromodulation platform for sensitisation of prostheses, and phantom pain management.
  • Debut issue of bonds on the Moscow Exchange.
  • Getting a BBB+.ru credit rating with a stable outlook from the National Credit Rating Agency.
  • Ranking in the top 3 largest medtech companies in Russia (according to Smart Ranking).
  • Getting the status of "National Champions".
2024

New development trends

  • Launching of 3 new business lines: leg prostheses, VNS/SCS Rishena invasive neurostimulators and wheelchairs.
  • Acquisition of 50.1% stake in the Zavod Spetsialnogo Oborudovaniya (ZSO) LLC and launch of a wheelchair production site.
  • Increase in the production volume of prosthetic arms by more than 1.5 times (maximum productivity is 10,000 prostheses per year).
  • Together with the Federal Center for Medical Sciences, establishment of the Centre for Cybernetic Medicine and Neuroprosthetics.
  • Improvement of the credit rating of Motorica LLC from "BBB+.ru" to "A–.ru" with a stable outlook (NCR).
2025

Unique developments in prosthetics and surgery

  • Release of the world's first prosthetic hand with Omni Hand optical sensors — they are able to read the user's intentions, which means that people with weakened muscles can control their prostheses more effectively.
  • Improvement of the credit rating of Motorica LLC from "A–.ru" to "A.ru" with a positive outlook (NCR).
  • The Centre for Cybernetic Medicine and Neuroprosthetics has received a grant from the Russian Government.
  • Together with the Vreden Center, we were the first in Russia to perform an osteointegrative endoprosthetics operation.

Motorica by numbers

Portfolio

62 products

prosthetic arms and legs, neurotechnology and >30 wheelchair models

In-house R&D

in sensitisation and phantom pain

>20 patents and know-how

in mobility

Motorica offers the widest range of functional prosthetic hands and ranks among the top 10 prosthetic hand manufacturers in the world, according to the Strategic Market Research 2021.

Sites

3 production sites

2 countries

with representative offices

2 mobility restoration centres

1 cybernetic medicine and neuroprosthetics centre

Production of 85% to 100% of components in Russia.

Online production tour
Personnel

600+ specialists

140 in the R&D team responsible for research and development of technologies that have no equivalents in the world

The team brings together scientists, engineers, medical professionals, and rehabilitation specialists — from technology development to installation of invasive neurointerfaces and patient care.